Navigation Links
Lifeline Skin Care™ Selects Click Here, Inc., Richards Partners

DALLAS, April 19, 2011 /PRNewswire/ -- Click Here, Inc., and Richards Partners have been selected as agencies of record by Lifeline Skin Care™, a wholly owned subsidiary of International Stem Cell Corporation (OTCBB: ISCO), a California-based biotechnology company focused on therapeutic and research products.  Lifeline offers luxury anti-aging skin care products developed using its proprietary stem cell technology.  Based in Dallas and part of The Richards Group – the nation's largest independent branding agency – Click Here will manage the digital marketing strategy and Richards Partners will oversee public relations initiatives.

Lifeline's products are developed by a team of ISCO scientists in collaboration with world-renowned cosmetic experts, and offer a comprehensive approach to skin care using patent pending moisture serums for day and night use.  Made with human non-embryonic stem cell extracts, the serums deliver anti-aging effects by nurturing collagen and elastin, resulting in healthier and younger-looking skin.  The products can be purchased through the website.

Tiffani Mauldin-Frederick, marketing partner of Lifeline Skin Care™ says, "Our partnership with these talented groups will provide additional momentum by developing strategic, engaging communications.  I am thrilled with the media reach and innovative approach provided by Richards Partners, and look forward to working with them to increase the brand recognition of Lifeline Skin Care™, and to help educate the public about the revolutionary science behind these products."

Lifeline was formed to support the research of the ISCO, a global leader in parthenogenetic stem cell technology to treat incurable human diseases such as diabetes, Parkinson's, liver and eye diseases.  Each purchase of Lifeline Skin Care™ products contributes to ISCO's search to cure these diseases.

"We are eager to support Lifeline's innovative products and unprecedented biotechnology research," said James Hering, principal at Click Here.  "Click Here and Richards Partners are uniquely suited to work in tandem, developing and deploying an overarching communications strategy for this growing company."

About Lifeline Skin Care/ISCO

Lifeline Skin Care™ is a wholly owned subsidiary of the International Stem Cell Corporation (OTCBB: ISCO), a publicly traded biotechnology company that has developed a powerful, ethical stem cell technology called parthenogenesis.  ISCO's core technology, parthenogenesis, results in creation of pluripotent human stem cells from unfertilized oocytes (eggs).  These proprietary cells avoid ethical issues associated with use or destruction of viable human embryos and, unlike most other major stem cell types, can be immune matched and be a source of therapeutic cells with minimal rejection after transplantation into hundreds of millions of individuals of differing racial groups.  ISCO is advancing novel human stem cell-based therapies where cells have been proven to be efficacious but traditional small molecule and protein therapeutics have not. More information is available on ISCO's website,

About Click Here

Established in 1995, Click Here is a veteran in digital marketing.  As the digital division of The Richards Group, Click Here builds brands online using an integrated mix of strategy, marketing and technology.  The agency's services include developing and deploying digital strategies, online experiences, digital advertising campaigns, search engine marketing and social media initiatives.  With more than 100 employees, Click Here works with such notable clients as Amstel Light, Chick-fil-A, The Home Depot, Fruit of the Loom, GameStop and The Salvation Army.  Total billings for the agency were $160 million in 2010.  For more information, visit

About Richards Partners

Richards Partners, an affiliate of The Richards Group, is a full service agency, specializing in consumer, corporate and nonprofit public relations and brand development.  Current clients include the American Heart Association, Behringer Harvard, Children's Medical Center Dallas, Honeywell, Nomacorc, Sub-Zero Freezer Company and Wolf Appliance, Inc.

SOURCE Lifeline Skin Care
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Solos Endoscopy, Inc. Sells Ovascope and Mastascope Product Line to Lifeline Biotechnologies, Inc.
2. Catalysis Foundation for Health Selects BioFortis Labmatrix Database Software for International Tuberculosis Diagnostic Biomarker Study
3. Top 5 Global Pharmaceutical Company Selects NewCardios QTinno for 2 Upcoming Phase I Drug Safety Trials
4. West Coast Clinical Trials Selects OmniComm Systems TrialOne® Suite to Automate Phase I Clinic Operations
5. Rush-Copley Medical Center Selects Pharmacy Xpert from Thomson Reuters to Improve Medication Management
6. Susquehanna Health Selects Perioperative and Anesthesia Automation Solution from Surgical Information Systems
7. DAIICHI SANKYO EUROPE GmbH Selects DATATRAK eClinical™ for Pan-European Systolic Hypertension Study
8. Allergy and Asthma Associates Selects ITelagen for Hosting and Management of EHR
9. Gilson, Inc. Selects EDL Consulting's CloudCraze For Cross-Channel Webstore Expansion in Europe
10. Vanderbilt University Hospital Selects Allscripts Care Management
11. Invida Selects LaVoie Group as Public Relations Agency of Record
Post Your Comments:
(Date:11/27/2015)... Kingdom , Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc ... company, announced today that it has closed the sale ... business to Guerbet (GBT- NYSE Euronext) in a transaction ... encompassed four manufacturing facilities and a total of approximately ... in the St. Louis area. ...
(Date:11/26/2015)... , November 26, 2015 ... --> Accutest Research Laboratories, a ... Research Organization (CRO), has formed a ... Center - Temple Health for joint ... ,     (Photo: ) , ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 ... a biotechnology company developing bioengineered organ implants for life-threatening ... will present at the LD Micro "Main Event" investor ... PT. The presentation will be webcast live and posted ... also be available at the conference for one-on-one meetings ...
Breaking Biology Technology:
(Date:11/19/2015)... NEW YORK , Nov. 19, 2015  Although ... the market is dominated by a few companies, according ... Qiagen. These companies own 51% of the market share of ... report, The World Market for Molecular Diagnostic ... "The market is still controlled by one ...
(Date:11/17/2015)... -- Paris from 17 th ... Paris from 17 th until 19 th ... has invented the first combined scanner in the world which ... surface. Until now two different scanners were required: one for ... on the same surface. This innovation is an ideal ...
(Date:11/17/2015)... , Nov. 17, 2015 Pressure BioSciences, ... in the development and sale of broadly enabling, pressure ... life sciences industry, today announced it has received gross ... $5 million Private Placement (the "Offering"), increasing the total ...  One or more additional closings are expected in the ...
Breaking Biology News(10 mins):